Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Coming to grips with bone loss.

× No keyword cloud information.

12 in total

1. Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study.

Authors: Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Adolfo Garcia-Ocaña; Alessandro Bisello; Bruce W Hollis; Caren Gundberg; Andrew F Stewart
Journal: Osteoporos Int Date: 2005-09-07 Impact factor: 4.507

2. Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women.

Authors: Lee-Jane W Lu; Fatima Nayeem; Karl E Anderson; James J Grady; Manubai Nagamani
Journal: J Nutr Date: 2008-12-23 Impact factor: 4.798

3. Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study.

Authors: Graeme M Campbell; Michael S Ominsky; Steven K Boyd
Journal: Osteoporos Int Date: 2010-05-18 Impact factor: 4.507

4. Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors.

Authors: George Pan; Michael Kilby; Jay M McDonald
Journal: AIDS Res Hum Retroviruses Date: 2006-11 Impact factor: 2.205

5. Combined treatment with parathyroid hormone (1-34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model.

Authors: Zhou-Shan Tao; Kai-Kai Tu; Zheng-Liang Huang; Qiang Zhou; Tao Sun; Hong-Ming Xu; Yu-Long Zhou; Yang-Xun Lv; Wei Cui; Lei Yang
Journal: Med Biol Eng Comput Date: 2015-10-01 Impact factor: 2.602

6. The G-protein-coupled receptor GPR103 regulates bone formation.

Authors: Helene Baribault; Jean Danao; Jamila Gupte; Li Yang; Banghua Sun; William Richards; Hui Tian
Journal: Mol Cell Biol Date: 2006-01 Impact factor: 4.272

7. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.

Authors: Stavroula Kousteni; Maria Almeida; Li Han; Teresita Bellido; Robert L Jilka; Stavros C Manolagas
Journal: Mol Cell Biol Date: 2006-12-11 Impact factor: 4.272

8. miR-214 targets ATF4 to inhibit bone formation.

Authors: Xiaogang Wang; Baosheng Guo; Qi Li; Jiang Peng; Zhijun Yang; Aiyuan Wang; Dong Li; Zhibo Hou; Ke Lv; Guanghan Kan; Hongqing Cao; Heng Wu; Jinping Song; Xiaohua Pan; Qiao Sun; Shukuan Ling; Yuheng Li; Mu Zhu; Pengfei Zhang; Songlin Peng; Xiaoqing Xie; Tao Tang; An Hong; Zhaoxiang Bian; Yanqiang Bai; Aiping Lu; Yinghui Li; Fuchu He; Ge Zhang; Yingxian Li
Journal: Nat Med Date: 2012-12-09 Impact factor: 53.440

9. miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1.

Authors: Yasir Arfat; Muhammad Asim R Basra; Muhammad Shahzad; Kashif Majeed; Nasir Mahmood; Hina Munir
Journal: Mol Ther Nucleic Acids Date: 2017-11-24 Impact factor: 8.886

10. AAV-Anti-miR-214 Prevents Collapse of the Femoral Head in Osteonecrosis by Regulating Osteoblast and Osteoclast Activities.

Authors: Cheng Wang; Weijia Sun; Shukuan Ling; Yu Wang; Xin Wang; Haoye Meng; Yuheng Li; Xueling Yuan; Jianwei Li; Ruoxi Liu; Dingsheng Zhao; Qiang Lu; Aiyuan Wang; Quanyi Guo; Shibi Lu; Hua Tian; Yingxian Li; Jiang Peng
Journal: Mol Ther Nucleic Acids Date: 2019-10-18 Impact factor: 8.886